Mapping the Clinical and Molecular landscape of childhood renal tumors: with a special focus on relapsed Wilms tumors.
Clinical factors combined with genomic and transcriptomic insights can improve relapse-risk identification, patient stratification, and therapeutic target discovery in relapsed WT and tRCC, demonstrating how clinical factors combined with genomic and transcriptomic insights can improve relapse-risk identification, pati...